From animal models to patient-derived cells: Why iPSCs are reshaping drug discovery ?​  ​

Dr. Amit Khanna discusses

“From Animal Models to Patient-Derived Cells: Why iPSCs Are Reshaping Drug Discovery”

During the talk, Dr. Khanna:

• Explains why traditional animal models fail to accurately predict human drug efficacy and toxicity.
• Highlights the role of patient-derived iPSC models in improving clinical predictivity and reducing late-stage failures.
• Discusses regulatory support for iPSC-based New Approach Methodologies (NAMs) and their growing adoption in drug discovery.